KNOP1P5: A Promising Drug Target / Biomarker (G100130158)

Target Name: KNOP1P5

NCBI ID: G100130158

KNOP1P5

Other Name(s): Chromosome 16 open reading frame 88 pseudogene | lysine rich nucleolar protein 1 pseudogene 5 | LOC100130158

KNOP1P5: A Promising Drug Target / Biomarker

Knop1p5 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the known as the knop family, which includes several similar proteins that play a critical role in various cellular processes. One of the most interesting aspects of Knop1p5 is its potential as a drug target or biomarker. In this article, we will explore the biology of Knop1p5, its potential drug targets, and its role as a biomarker for various diseases.

Structure and Function

Knop1p5 is a protein that consists of 129 amino acid residues. It has a molecular weight of 18.1 kDa and a calculated pI of 7.4. Knop1p5 is a monomer that is expressed in the brain, heart, and kidneys. It is highly expressed in the brain, with a protein expression level of approximately 15% of total protein in the brain. Knop1p5 is also expressed in other tissues, including the heart and kidneys, where its expression level is less.

Knop1p5 is involved in various cellular processes, including the regulation of cell adhesion, migration, and invasion. It is a critical protein that is involved in the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of tissues. Knop1p5 is also involved in the regulation of mitochondrial function and in the regulation of ion channels in the brain.

Potential Drug Targets

Knop1p5 is a potential drug target due to its unique structure and function. The Knop1p5 protein is involved in various cellular processes that are critical for the development and progression of various diseases. One of the most promising aspects of Knop1p5 as a drug target is its involvement in cancer. Knop1p5 has been shown to be involved in the regulation of cell adhesion and migration, which are critical processes in the development of cancer. Therefore, targeting Knop1p5 with small molecules or antibodies that can inhibit its function may be an effective way to treat various cancers.

Another potential drug target for Knop1p5 is its role in the regulation of cardiovascular disease. Knop1p5 is involved in the regulation of mitochondrial function and in the regulation of ion channels in the heart. Therefore, targeting Knop1p5 with small molecules or antibodies that can inhibit its function may be an effective way to treat various cardiovascular diseases, including heart failure, hypertension, and myocardial infarction.

In addition to its potential as a cancer and cardiovascular drug target, Knop1p5 may also be a biomarker for various diseases. Knop1p5 is highly expressed in the brain, which suggests that it may be involved in the regulation of brain function. Therefore, Knop1p5 may be a useful biomarker for various neurological diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative diseases.

Role as a Biomarker

Knop1p5 has been shown to be involved in the regulation of various cellular processes that are critical for the development and progression of various diseases. Therefore, Knop1p5 may be a useful biomarker for various diseases. One of the most promising aspects of Knop1p5 as a biomarker is its expression in the brain, which suggests that it may be involved in the regulation of brain function.

Studies have shown that Knop1p5 is highly expressed in the brain and that its expression is associated with the development and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative diseases. In addition, Knop1p5 has been shown to be involved in the regulation of cellular processes that are critical for the development

Protein Name: Lysine Rich Nucleolar Protein 1 Pseudogene 5

The "KNOP1P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KNOP1P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets